A study of over 450,000 NSTEMI admissions reveals that diabetics face disparities in care, with less invasive treatment ...

Javier Escaned, Hospital Clinico San Carlos IDISSC, Complutense University of Madrid and CIBERCV, Madrid, Spain, and ...

The Global Myocardial Infarction Therapeutics Market is estimated to be valued at USD 15.56 billion in 2023 and is projected to grow at a CAGR of 4.19% over the forecast period 2024-2032. Read the ...

While women are thought to generally have greater protection than men against CVD due to estrogen, women have been shown to ...

18 The time relations between the onset of myocardial infarction and death have not been adequately studied. Most reviews concerning the immediate prognosis of myocardial infarction lump all ...

Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...

The following is a summary of “Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST-Elevation Myocardial Infarction—A Matched Case-Control Study,” published in the October ...

Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply.

Early use of mechanical circulatory support did not reduce 6-month all-cause mortality. 2. MCS was associated with increased ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...